Vaccines and Other Medical Materials Updated During 2011, From Oldest to Newest, Page 2

Page 2 of 20 « 1 2 3 4 5 » 10 15 20 … Last Page »

ROTARIX

Rotavirus Vaccine, Live, Oral

By GlaxoSmithKline Biologicals SA | Last revised: 24 February 2011

ROTARIX^® is indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3. G4, and G9) when administered as a 2-dose series [see Clinical Studies (14.3)]. ROTARIX is approved for use in infants 6 weeks to 24 weeks of…

GENTAMICIN SULFATE

By Yicheng Chemical Corp. | Last revised: 8 March 2011

YCC-GTMC-label YCC-GTMC-label.jpg. SCC’s label for YCC-GTMC: YCC-GTMC-label.jpg

Fomepizole

By Seratec S.A.S. | Last revised: 8 March 2011

Fomepizole image of Fomepizole

NITROFURANTOIN

By Yicheng Chemical Corp. | Last revised: 9 March 2011

YCC-NTFR-label YCC-NTFR-label.jpg. YCC’s label for NTFR: YCC-NTFR-label.jpg

ActHIB

HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

By Sanofi Pasteur Inc. | Last revised: 10 March 2011

ActHIB vaccine or ActHIB vaccine combined with Sanofi Pasteur Inc. DTP vaccine by reconstitution is indicated for the active immunization of infants and children 2 through 18 months of age for the prevention of invasive disease caused by H…

Page 2 of 20 « 1 2 3 4 5 » 10 15 20 … Last Page »

FDA MedWatch

Zithromax (azithromycin): FDA Statement on risk of cardiovascular death
Thu, 17 May 2012. A retrospective cohort study reports small increase in risk of cardiovascular deaths and risk of all cause deaths associated with 5 day course of antibiotic drug
Gilenya (fingolimod): Drug Safety Communication – Safety Review of a Reported Death After the First Dose
Mon, 14 May 2012. UPDATED 05/14/2012. New recommendations for monitoring patients, and new contraindications, and dosing & administration information for use in certain patients.